We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

143 hedge funds and large institutions have $236M invested in Filana Therapeutics in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $46M | Put options by funds: $32.9M

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 153 → 143 (-10)

7.46% less ownership

Funds ownership: 34.32% → 26.86% (-7.5%)

28% less capital invested

Capital invested by funds: $326M → $236M (-$90M)

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
143
Holders Change
-10
Holders Change %
-6.54%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
47
Reduced
43
Closed
25
Calls
$46M
Puts
$32.9M
Net Calls
+$13.2M
Net Calls Change
-$11.6M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$734K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$642K
3
Wolverine Trading
Wolverine Trading
Illinois
+$613K
4
State Street
State Street
Massachusetts
+$549K
5
PI
PFG Investments
New York
+$504K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$20.2M
2
CAC
Cowen and Company
New York
-$11.3M
3
Jane Street
Jane Street
New York
-$6.4M
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$5.97M
5
N
Nuveen
North Carolina
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
126
Quadrant Capital Group
Ohio
$1.99K – – –
EWA
127
EverSource Wealth Advisors
Alabama
$1.88K +$1.84K +80 +1,600%
SWA
128
SOA Wealth Advisors
New York
$1.58K – – –
GWM
129
Geneos Wealth Management
Colorado
$1.52K – – –
WTA
130
Washington Trust Advisors
Massachusetts
$1.52K – – –
Northwestern Mutual Wealth Management
131
Northwestern Mutual Wealth Management
Wisconsin
$1.42K -$3.34K -145 -67%
FCMT
132
Founders Capital Management (Texas)
Texas
$1.42K – – –
S
133
SignatureFD
Georgia
$1.1K +$253 +11 +26%
HPC
134
HM Payson & Co
Maine
$1.01K – – –
PS
135
Principal Securities
Iowa
$1.01K – – –
CWA
136
Carolina Wealth Advisors
South Carolina
$973 – – –
SWM
137
Spire Wealth Management
Virginia
$609 – – –
FFO
138
Fortitude Family Office
Arizona
$345 -$737 -32 -65%
LI
139
LRI Investments
Florida
$203 +$230 +10 New
AWM
140
Avior Wealth Management
Nebraska
$162 +$184 +8 New
GI
141
GAMMA Investing
California
$142 +$161 +7 New
RIL
142
Rothschild Investment LLC
Illinois
$101 +$115 +5 New
CAC
143
Cowen and Company
New York
– -$11.3M -500,000 Closed
SG Americas Securities
144
SG Americas Securities
New York
– -$2.08M -92,359 Closed
Millennium Management
145
Millennium Management
New York
– -$1.43M -66,885 Closed
Neuberger Berman Group
146
Neuberger Berman Group
New York
– -$1.34M -59,528 Closed
CCC
147
Cable Car Capital
California
– -$1.2M -53,500 Closed
VF
148
Virtu Financial
New York
– -$1.11M -49,128 Closed
Balyasny Asset Management
149
Balyasny Asset Management
Illinois
– -$948K -42,099 Closed
EGM
150
Engineers Gate Manager
New York
– -$838K -37,249 Closed
3 4 5
6
7

FLNA Hedge Fund Activity: Q1 2024 in Review

143 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2024, worth a combined $236M — down 28% from $326M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of FLNA and 15 opened new positions — a net loss of 10 holders — while 43 trimmed existing stakes and 47 added.

The largest buyer was Vanguard Group, adding an estimated $734K. The largest seller was Morgan Stanley, cutting an estimated $20.2M.

  • 143 institutional investors held Filana Therapeutics (FLNA) as of Q1 2024, down from 153 in Q4 2023.
  • Funds reported $236M of Filana Therapeutics stock for Q1 2024, down 28% quarter-over-quarter.
  • 15 funds opened new Filana Therapeutics positions in Q1 2024 and 25 closed out, a net change of -10 holders.
  • The largest Filana Therapeutics buyer in Q1 2024 was Vanguard Group, an estimated $734K added.
  • The largest Filana Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $20.2M sold.

Based on aggregated 13F filings for Q1 2024.